Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.39), $0.07 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.